RBM-007 in Treatment naïve Exudative Age-related Macular Degeneration (TEMPURA)

  • STATUS
    Recruiting
  • participants needed
    5
  • sponsor
    Maturi, Raj K., M.D., P.C.
Updated on 19 August 2022
edema
neovascularization
corrected visual acuity

Summary

This study is a single-center, open label, 4-month study, designed to evaluate the safety and treatment efficacy of RBM-007 in patients with intraretinal or subretinal edema due to previously untreated neovascular AMD. Up to 5 subjects will be randomized to receive study medication. Study treatment will be administered by intravitreal injections.

Details
Condition Age Related Macular Degeneration
Treatment RBM-007 Injectable Solution
Clinical Study IdentifierNCT04895293
SponsorMaturi, Raj K., M.D., P.C.
Last Modified on19 August 2022

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note